All News
Systemic Steroids Seldom Flare Psoriasis
A tenet of drug management suggests that steroid use in psoriasis may be associated with rebound flares; well this has been challenged by a new observational trial showing that the risk of flares (and severe flares) of psoriasis flares were seldom triggered by systemic steroids - certainly much l
Read Article
#FDA, Summary of Dr. Aron Halls CDC presentation and updates on COVID-19 https://t.co/DUAftAKq0R
Dr. John Cush RheumNow ( View Tweet)
#FDA hearing on Covid vaccines - shows current seroprevalence by state, currently < 10% seroprevalence with higher rates in children and young adults https://t.co/8eG5cKQBiA
Dr. John Cush RheumNow ( View Tweet)
#UTSW Rheum Grand Rounds. IN Sarcoidosis, lymph node bx is not necessary with Loffgrens syndrome (below), lupus pernio rash, uveoparotid fever. @UTSWIMchief https://t.co/SYvuc1gLRy
Dr. John Cush RheumNow ( View Tweet)
#UTSW Rheum Grand Rounds on Sarcoidosis w/ Dr. HSIA - Joints are involved in 15% of pts. Lung sking and ocular involvement predominate https://t.co/G4iWm4pLmO
Dr. John Cush RheumNow ( View Tweet)
Dr. Connie Hsia from #UTSW shows that the frequency of #Sarcoidosis is increasing; there is familial clustering, higher risk in firefighters, WTC, insecticides, construction, organic dust, fumes, smokers https://t.co/hDQV4MmZNt
Dr. John Cush RheumNow ( View Tweet)
Medicare Physician Fee Schedule Final Rule Released
https://t.co/UvGQ5PIQEk https://t.co/ZuivQr5jKO
Links:
Dr. John Cush RheumNow ( View Tweet)
Read our article, Mortality in Low Dose Prednisone by Dr. Eric Dein ( @ejdein1) , covering #ACR20 abstracts.
https://t.co/y6dL9V6iDC https://t.co/c39ovUJAPz
Links:
Dr. John Cush RheumNow ( View Tweet)
Pregnancy and ILD: Dr. David Liew ( @drdavidliew) reviews abstract #1446 presented at #ACR20.
https://t.co/1g5KUdG6XW
Links:
Dr. John Cush RheumNow ( View Tweet)
Hepatitis B, RA and Drug Risk with Drs. Stanley Cohen and Jack Cush #ACR20
https://t.co/jOzAkLzNEc https://t.co/A377Ti9zvX
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @MeralElRamahiMD :Largest to date cohort study of pregnancies in women w/ ILD showed no mat. deaths suggesting that women w/ ILD may not need to avoid conception or terminate pregnancies, but pts w/ severe ILD were at higher risk for poor pregnancy outcomes.
Dr. John Cush RheumNow ( View Tweet)
GCA Treatment Data: Dr. David Liew ( @drdavidliew) reviews abstracts #0516 and #0513 presented at the #ACR20.
https://t.co/Czi0jiHa00 https://t.co/uGEaFWGpIC
Links:
Dr. John Cush RheumNow ( View Tweet)
A look back on Day 5 of #ACR20. Listen to more recaps at the RheumNow podcast found on Apple and Android devices.
https://t.co/sd0J9ZnRpK
Links:
Dr. John Cush RheumNow ( View Tweet)
Delays in Diagnosis - Axial Spondyloarthritis: Dr Antoni Chan ( @synovialjoints) reviews abstracts #1303 and #1306 presented at the #ACR20.
https://t.co/k7L2ebXcGb https://t.co/6oQ8fWpVCQ
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @DrMiniDey : Plenty of great telemed posters in ""Measures; Measurement of Healthcare Quality"" session! Abs#1584 reports telemedicine improves access to #rheum clinics; adherence, eg in those prev without adequate transport provision.
https://t.co/BbTnprwbat https://t.co/d8lbs2b8Ca
Links:
Dr. John Cush RheumNow ( View Tweet)
Read our latest titled: "ACIP Recommendations for Pfizer Vaccine Candidate" by Dr. Rachel Tate ( @uptoTate )
https://t.co/aTUoGTFrbh https://t.co/NpwrGTc0ZU
Links:
Dr. John Cush RheumNow ( View Tweet)
RT @doctorRBC : Deucravacitinib TYK2i for PsA
Phase2b 16wk, Double-blind, Placebo, RCT
⬆️ACR20/50/70 response vs. PBO
⬆️HAQ-DI response, enthesitis resolution, MDA vs. PBO
*⃣No serious AE
@RheumNow #ACR20 Abs#L03 #ACRbest https://t.co/LeMBj3XQo4" https://t.co/U9fB5hgcJY
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @KDAO2011 : Big wins for #pedirheum!
#FDA had approved for JIA;2 y.o:
9/29 golimumab iV for JIA/PsA
9/25 tofacitinib (weight based dosing) for polyarticular JIA (tofacitinib dosing for JIA: 10 kg-20kg: 3.2 mg bid, for 20-40 kg 4 mg bid, for 40 kg 5 mg bid)
Dr. John Cush RheumNow ( View Tweet)
ABCs of RA: Panel Discussion with Dr. Jonathan Kay #acr20
https://t.co/9HTTyPjCBV https://t.co/uDtS2EsMng
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @ejdein1 : Abst#1993 main finding: no difference in primary outcome in Medicare study of MTX vs HCQ MACE events. Secondary analys: greater stroke risk, lower MI and hospitalized HF in MTX pts but hard to know what is causal in large database study. https://t.co/h9wAKkSlVa
Dr. John Cush RheumNow ( View Tweet)